• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西新冠疫情规模的大流行后概况:一项全国性研究。

A post-pandemic snapshot of the magnitude of COVID-19 in Brazil: A countrywide study.

作者信息

Kohn Eduardo Ribes, Bohlke Maristela, Almeida Antônia, Janelli Leandro, Sardinha Luciana Monteiro Vasconcelos, Wehrmeister Fernando C, Hallal Pedro Curi

机构信息

Universidade Federal de Pelotas, Programa de Pós-Graduação em Educação Física, Pelotas, RS, Brasil.

Universidade Católica de Pelotas, Programa de Pós-Graduação em Saúde, Pelotas, RS, Brasil.

出版信息

Braz J Infect Dis. 2025 Jan-Feb;29(1):104496. doi: 10.1016/j.bjid.2024.104496. Epub 2024 Dec 21.

DOI:10.1016/j.bjid.2024.104496
PMID:39709886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11730850/
Abstract

OBJECTIVE

To outline the features of COVID-19 in Brazil through a countrywide telephone survey.

METHODS

Data from the Telephone Survey of Risk Factors for Chronic Noncommunicable Diseases During the Pandemic (Covitel), a telephone survey of individuals aged 18 years or older from all macro-regions of Brazil, were used. The questionnaire included sociodemographic characteristics and outcomes related to COVID-19 infection, severity, vaccination, and use of masks.

RESULTS

Data revealed that 34.7 % (95 %CI 32.4 - 37.1) of the population had been diagnosed with COVID-19, and 10.1 % (95 %CI 7.9 - 12.7) of those required hospital admission. The prevalence of COVID-19 diagnosis increased with education level: <8 years (26.6 % [95 %CI 23.1 - 30.7]), 9-11 years (33.4 % [95 %CI 29.4 - 37.7]), and >11 years (53.2 % [95 % CI 49.7 - 56.8]). Nevertheless, the hospitalization rate of Brazilians with more than eleven years of education was lower (5.8 % [95 %CI 4.3 - 7.6]). In 2023, 92.9 % (95 %CI 90.9 - 94.4) of the Brazilian population was fully vaccinated against COVID-19, but only 37.2 % (95 %CI 33.5 - 40.9) have received the updated vaccinal scheme (two doses and two boosters). During the pandemic outbreak, 81.9 % (95 %CI 79.4 - 84.2) reported always using face masks. However, only 16.1 % (95 %CI 13.5 - 19.0) maintained this practice in 2023.

CONCLUSION

There were inequalities in COVID-19 testing in Brazil. Testing and vaccination policies implemented in the COVID-19 pandemic must be reevaluated by the Brazilian government.

摘要

目的

通过一项全国性电话调查概述巴西新冠肺炎的特征。

方法

使用了大流行期间慢性非传染性疾病风险因素电话调查(Covitel)的数据,该调查对巴西所有宏观区域18岁及以上的个人进行电话访谈。问卷包括社会人口学特征以及与新冠病毒感染、严重程度、疫苗接种和口罩使用相关的结果。

结果

数据显示,34.7%(95%置信区间32.4 - 37.1)的人口被诊断感染过新冠病毒,其中10.1%(95%置信区间7.9 - 12.7)需要住院治疗。新冠病毒诊断的患病率随教育程度升高而增加:<8年教育程度者为26.6%(95%置信区间23.1 - 30.7),9 - 11年教育程度者为33.4%(95%置信区间29.4 - 37.7),>11年教育程度者为53.%(95%置信区间49.7 - 56.8)。然而,教育年限超过11年的巴西人的住院率较低(5.8%[95%置信区间4.3 - 7.6])。2023年,92.9%(95%置信区间90.9 - 94.4)的巴西人口完成了新冠病毒疫苗全程接种,但只有37.2%(95%置信区间33.5 - 40.9)接种了更新后的疫苗接种方案(两剂疫苗和两剂加强针)。在疫情爆发期间,81.9%(95%置信区间79.4 - 84.2)的人报告一直使用口罩。然而,2023年只有16.1%(95%置信区间13.5 - 19.0)的人保持了这一习惯。

结论

巴西在新冠病毒检测方面存在不平等现象。巴西政府必须重新评估在新冠疫情期间实施的检测和疫苗接种政策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aef/11730850/4dc46556ebc7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aef/11730850/4dc46556ebc7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aef/11730850/4dc46556ebc7/gr1.jpg

相似文献

1
A post-pandemic snapshot of the magnitude of COVID-19 in Brazil: A countrywide study.巴西新冠疫情规模的大流行后概况:一项全国性研究。
Braz J Infect Dis. 2025 Jan-Feb;29(1):104496. doi: 10.1016/j.bjid.2024.104496. Epub 2024 Dec 21.
2
COVID-19 diagnosis and hospital admissions in Brazil: a countrywide survey (Covitel, 2022).巴西的 COVID-19 诊断和住院情况:一项全国性调查(Covitel,2022 年)。
Rev Bras Epidemiol. 2024 Nov 22;27:e240052. doi: 10.1590/1980-549720240052. eCollection 2024.
3
Impact of emergency financial support program on testing demand, SARS-CoV-2 prevalence, and social isolation during COVID-19 outbreak in Brazil: a quasi-experimental study.紧急财政支持计划对巴西新冠疫情期间检测需求、新冠病毒流行率及社会隔离的影响:一项准实验研究
BMC Public Health. 2024 Dec 18;24(1):3435. doi: 10.1186/s12889-024-20877-z.
4
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.巴西的 SARS-CoV-2 抗体流行率:两项连续全国血清学家庭调查结果。
Lancet Glob Health. 2020 Nov;8(11):e1390-e1398. doi: 10.1016/S2214-109X(20)30387-9. Epub 2020 Sep 23.
5
Second booster doses of adenoviral- and mRNA-based COVID-19 vaccines increase protection against COVID-19 hospitalization: Final analysis from the REFORCO-Brazil real-world effectiveness study during Omicron.基于腺病毒和信使核糖核酸的新冠疫苗第二剂加强针可增强预防新冠住院治疗的保护效果:来自巴西REFORCO在奥密克戎毒株流行期间的真实世界有效性研究的最终分析
Vaccine. 2025 Apr 19;53:126955. doi: 10.1016/j.vaccine.2025.126955. Epub 2025 Mar 10.
6
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.以色列全国疫苗接种运动后,mRNA BNT162b2疫苗对SARS-CoV-2感染及COVID-19病例、住院和死亡的影响与效果:一项利用国家监测数据的观察性研究
Lancet. 2021 May 15;397(10287):1819-1829. doi: 10.1016/S0140-6736(21)00947-8. Epub 2021 May 5.
7
[Telephone Survey of Risk Factors for Chronic Noncommunicable Diseases During the Pandemic (Covitel): methodological aspects].[大流行期间慢性非传染性疾病风险因素的电话调查(Covitel):方法学方面]
Cad Saude Publica. 2023 Sep 25;39(9):e00248922. doi: 10.1590/0102-311XPT248922. eCollection 2023.
8
Association Between Risk Factors for Complications From COVID-19, Perceived Chances of Infection and Complications, and Protective Behavior in the US.美国与 COVID-19 并发症风险因素、感染和并发症感知几率以及防护行为的关联。
JAMA Netw Open. 2021 Mar 1;4(3):e213984. doi: 10.1001/jamanetworkopen.2021.3984.
9
Healthcare institutions' recommendation regarding the use of FFP-2 masks and SARS-CoV-2 seropositivity among healthcare workers: a multicenter longitudinal cohort study.医疗机构关于 FFP-2 口罩使用的建议和医护人员中 SARS-CoV-2 血清阳性率:一项多中心纵向队列研究。
Antimicrob Resist Infect Control. 2022 Jan 10;11(1):6. doi: 10.1186/s13756-021-01047-x.
10
Perception of Risk for Developing Severe Illness or Complications from COVID-19 in Brazil: Focus on Factors Linked to Socially Vulnerable Populations, 2020-2023.巴西对感染新冠病毒发展为重症或出现并发症风险的认知:关注与社会弱势群体相关的因素,2020 - 2023年
Int J Environ Res Public Health. 2025 Feb 11;22(2):251. doi: 10.3390/ijerph22020251.

本文引用的文献

1
Investigating the 'Bolsonaro effect' on the spread of the Covid-19 pandemic: An empirical analysis of observational data in Brazil.研究“博索纳罗效应”对新冠疫情传播的影响:对巴西观测数据的实证分析。
PLoS One. 2024 Apr 18;19(4):e0288894. doi: 10.1371/journal.pone.0288894. eCollection 2024.
2
Cognitive Symptoms of Post-COVID-19 Condition and Daily Functioning.新冠后症状与日常功能认知。
JAMA Netw Open. 2024 Feb 5;7(2):e2356098. doi: 10.1001/jamanetworkopen.2023.56098.
3
[Telephone Survey of Risk Factors for Chronic Noncommunicable Diseases During the Pandemic (Covitel): methodological aspects].
[大流行期间慢性非传染性疾病风险因素的电话调查(Covitel):方法学方面]
Cad Saude Publica. 2023 Sep 25;39(9):e00248922. doi: 10.1590/0102-311XPT248922. eCollection 2023.
4
Estimated COVID-19 severe cases and deaths averted in the first year of the vaccination campaign in Brazil: A retrospective observational study.巴西疫苗接种运动第一年避免的估计新冠重症病例和死亡:一项回顾性观察研究。
Lancet Reg Health Am. 2023 Jan;17:100418. doi: 10.1016/j.lana.2022.100418. Epub 2022 Dec 22.
5
Overcoming Brazil's monumental COVID-19 failure: an urgent call to action.克服巴西在新冠疫情应对上的巨大失败:紧急行动呼吁。
Nat Med. 2021 Jun;27(6):933. doi: 10.1038/s41591-021-01353-2.
6
Effect of socioeconomic inequalities and vulnerabilities on health-system preparedness and response to COVID-19 in Brazil: a comprehensive analysis.巴西社会经济不平等和脆弱性对新冠疫情防控准备和应对的影响:一项综合分析。
Lancet Glob Health. 2021 Jun;9(6):e782-e792. doi: 10.1016/S2214-109X(21)00081-4. Epub 2021 Apr 12.
7
Post-acute COVID-19 syndrome.新冠病毒感染后长期综合征。
Nat Med. 2021 Apr;27(4):601-615. doi: 10.1038/s41591-021-01283-z. Epub 2021 Mar 22.
8
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.新冠肺炎出院患者 6 个月的后果:一项队列研究。
Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8. Epub 2021 Jan 8.
9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
10
Sixty-Day Outcomes Among Patients Hospitalized With COVID-19.新冠病毒病住院患者的60天预后
Ann Intern Med. 2021 Apr;174(4):576-578. doi: 10.7326/M20-5661. Epub 2020 Nov 11.